ADGRB3
Adhesion G protein-coupled receptor B3
Also known as: AGRB3_HUMAN, BAI3, KIAA0550
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O60242
- Gene
- ADGRB3
- Ensembl
- ENSG00000135298
- Chromosome
- 6
- Canonical length
- 1522 aa
- Protein class
- G-protein coupled receptors, Plasma proteins, Predicted membrane proteins, Transporters
OverviewNCBI Gene
This p53-target gene encodes a brain-specific angiogenesis inhibitor, a seven-span transmembrane protein, and is thought to be a member of the secretin receptor family. Brain-specific angiogenesis proteins BAI2 and BAI3 are similar to BAI1 in structure, have similar tissue specificities, and may also play a role in angiogenesis. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
1522 residues, UniProt reviewed canonical sequence.
>O60242|ADGRB3
1 MKAVRNLLIY IFSTYLLVMF GFNAAQDFWC STLVKGVIYG SYSVSEMFPK NFTNCTWTLE
61 NPDPTKYSIY LKFSKKDLSC SNFSLLAYQF DHFSHEKIKD LLRKNHSIMQ LCNSKNAFVF
121 LQYDKNFIQI RRVFPTNFPG LQKKGEEDQK SFFEFLVLNK VSPSQFGCHV LCTWLESCLK
181 SENGRTESCG IMYTKCTCPQ HLGEWGIDDQ SLILLNNVVL PLNEQTEGCL TQELQTTQVC
241 NLTREAKRPP KEEFGMMGDH TIKSQRPRSV HEKRVPQEQA DAAKFMAQTG ESGVEEWSQW
301 STCSVTCGQG SQVRTRTCVS PYGTHCSGPL RESRVCNNTA LCPVHGVWEE WSPWSLCSFT
361 CGRGQRTRTR SCTPPQYGGR PCEGPETHHK PCNIALCPVD GQWQEWSSWS QCSVTCSNGT
421 QQRSRQCTAA AHGGSECRGP WAESRECYNP ECTANGQWNQ WGHWSGCSKS CDGGWERRIR
481 TCQGAVITGQ QCEGTGEEVR RCNEQRCPAP YEICPEDYLM SMVWKRTPAG DLAFNQCPLN
541 ATGTTSRRCS LSLHGVAFWE QPSFARCISN EYRHLQHSIK EHLAKGQRML AGDGMSQVTK
601 TLLDLTQRKN FYAGDLLMSV EILRNVTDTF KRASYIPASD GVQNFFQIVS NLLDEENKEK
661 WEDAQQIYPG SIELMQVIED FIHIVGMGMM DFQNSYLMTG NVVASIQKLP AASVLTDINF
721 PMKGRKGMVD WARNSEDRVV IPKSIFTPVS SKELDESSVF VLGAVLYKNL DLILPTLRNY
781 TVINSKIIVV TIRPEPKTTD SFLEIELAHL ANGTLNPYCV LWDDSKTNES LGTWSTQGCK
841 TVLTDASHTK CLCDRLSTFA ILAQQPREII MESSGTPSVT LIVGSGLSCL ALITLAVVYA
901 ALWRYIRSER SIILINFCLS IISSNILILV GQTQTHNKSI CTTTTAFLHF FFLASFCWVL
961 TEAWQSYMAV TGKIRTRLIR KRFLCLGWGL PALVVATSVG FTRTKGYGTD HYCWLSLEGG
1021 LLYAFVGPAA AVVLVNMVIG ILVFNKLVSR DGILDKKLKH RAGQMSEPHS GLTLKCAKCG
1081 VVSTTALSAT TASNAMASLW SSCVVLPLLA LTWMSAVLAM TDKRSILFQI LFAVFDSLQG
1141 FVIVMVHCIL RREVQDAFRC RLRNCQDPIN ADSSSSFPNG HAQIMTDFEK DVDIACRSVL
1201 HKDIGPCRAA TITGTLSRIS LNDDEEEKGT NPEGLSYSTL PGNVISKVII QQPTGLHMPM
1261 SMNELSNPCL KKENSELRRT VYLCTDDNLR GADMDIVHPQ ERMMESDYIV MPRSSVNNQP
1321 SMKEESKMNI GMETLPHERL LHYKVNPEFN MNPPVMDQFN MNLEQHLAPQ EHMQNLPFEP
1381 RTAVKNFMAS ELDDNAGLSR SETGSTISMS SLERRKSRYS DLDFEKVMHT RKRHMELFQE
1441 LNQKFQTLDR FRDIPNTSSM ENPAPNKNPW DTFKNPSEYP HYTTINVLDT EAKDALELRP
1501 AEWEKCLNLP LDVQEGDFQT EVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ADGRB3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 7
- Mean surface accessibility (rSASA)
- 0.43
- Highest tissue expression
- 28 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 28 nTPM
- pituitary gland: 21 nTPM
- basal ganglia: 21 nTPM
- cerebellum: 21 nTPM
- hypothalamus: 16 nTPM
- amygdala: 13 nTPM
Single-cell type
- brain excitatory neurons: 4,026 nCPM
- bergmann glia: 3,659 nCPM
- brain inhibitory neurons: 3,169 nCPM
- astrocytes: 2,909 nCPM
- oligodendrocyte progenitor cells: 2,893 nCPM
- other brain neurons: 1,915 nCPM
Immune cell
- plasmacytoid DC: 0.4 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- cerebellum: 174 nTPM
- cerebral cortex: 138 nTPM
- basal ganglia: 118 nTPM
- hypothalamus: 113 nTPM
- white matter: 112 nTPM
- hippocampal formation: 104 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ADGRB3.
Disease | GeneticClinVar
2 pathogenic / likely-pathogenic of 182 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.14
- gnomAD pLI
- 1
- DepMap mean gene effect
- -0.05
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell surface receptor signaling pathway
- G protein-coupled receptor signaling pathway
- maintenance of synapse structure
- motor learning
- myoblast fusion
- negative regulation of angiogenesis
- neuron remodeling
- positive regulation of synapse assembly
- regulation of dendrite morphogenesis
- regulation of synapse maturation
- regulation of synapse pruning
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- GPS motif
- GPCR, family 2, secretin-like
- CUB domain
- Thrombospondin type-1 (TSP1) repeat
- GPCR, family 2, extracellular hormone receptor domain
- GPCR, family 2, brain-specific angiogenesis inhibitor
- GPCR, family 2-like, 7TM
- GPCR, family 2, secretin-like, conserved site
- AGRL2-4 , GAIN subdomain A
- Thrombospondin type-1 repeat superfamily
- GPCR family 2, extracellular hormone receptor domain superfamily
- Adhesion G protein-coupled receptor B, N-terminal domain
- GAIN domain superfamily
- GAIN, subdomain B
- 7 transmembrane receptor (Secretin family)
- Thrombospondin type 1 domain
- GPCR proteolysis site, GPS, motif
- Hormone receptor domain
- AGRL2-4 GAIN subdomain A
- Adhesion GPCR B N-terminal region
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ADGRB3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ADGRB3 as an antibody target. Whether an autoantibody or antibody against ADGRB3 could matter depends on whether native ADGRB3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ADGRB3 is annotated at the cell surface, where native ADGRB3 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label ADGRB3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...